EASL SLD Summit 2025
The EASL SLD Summit 2025 has come to a close, we want to express our heartfelt gratitude to our delegates, faculty, organisers, and sponsors for your active engagement and enthusiasm throughout this extraordinary event! The SLD Summit counted 518 delegates…
Steatotic Liver Disease – from pathogenesis to treatment
Steatotic Liver Disease (SLD) is proposed to be the most prevalent liver disease Worldwide due to the close association with the metabolic syndrome and epidemic of obesity and type 2 diabetes. End-stage liver disease, development of hepatocellular carcinoma and increased…
Alcohol-related liver disease: diagnosis, risk stratification and management
This EASL school is dedicated to chronic alcohol related liver disease, covering all aspects of the patient’s journey through the healthcare system. From alcohol’s impact on citizens in the society, to early disease detection, biomarkers used in healthcare pathways from…
EASL SLD Summit 2023
As we draw the curtains on the EASL SLD Summit 2023, we extend our sincere thanks to each and every one of you for your participation and unwavering enthusiasm throughout this remarkable event. Your active participation has been instrumental in advancing our…
EASL NAFLD Summit 2022
NAFLD is the leading cause of chronic liver disease, along with higher risk of diabetes, cardiovascular disease, and cancer, and thus a major public health challenge. NAFLD represents a therapeutic area of as yet unmet clinical lead. This 4th iteration…
